CNN's Maeve Reston reports that Mitt Romney has signaled he is moving toward with a run for a US Senate seat from Utah, tweeting Thursday that he will make a formal announcement about his plans on February 15.
Mitt Romney, a former governor of MA, teased a major announcement on Twitter on Thursday regarding the Senate race in Utah, further stoking speculation that he's readying a campaign announcement.
The former MA governor is expected to announce he is running for retiring Sen.
Girl in Slender Man stabbing gets maximum mental commitment
The decision comes almost four years after Geyser and Anissa Weier took their classmate into the woods and stabbed her 19 times. She had pled guilty to second-degree intentional homicide as a party to a crime, but claimed she was mentally ill at the time.
This story will be updated.
"As Chairman of the Senate Finance and Judiciary Committees and as the longest-serving Republican Senator in USA history, Senator Hatch has represented the interests of Utah with distinction and honor", Romney said.
In early January, after, the White House pointedly would not commit to Trump supporting the eventual Republican nominee for Hatch's successor.
Alibaba Group (BABA) Upgraded by Vetr to "Strong-Buy"
Moving averages are considered to be lagging indicators, and they may prove to be very useful for spotting peaks and troughs. RBC Capital Markets maintained Alibaba Group Holding Limited (NYSE: BABA ) on Thursday, August 13 with "Outperform" rating.
While Romney has been quietly talking to potential aides in Utah, the tweet will allow him to hire a staff and make preparations more openly - while also courting the conservative delegates who control the Utah GOP's nominating convention. "Donald Trump is a phony, a fraud", Romney said during a speech in 2016.
Hatch said the following day that he would support Romney is he chooses to run.
A recent Salt Lake Tribune poll showed Romney winning the senate race with 64 percent over likely Democratic challenger Jenny Wilson, who had 19 percent.
Celgene (CELG) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS
The firm owned 10,296 shares of the biopharmaceutical company's stock after buying an additional 2,242 shares during the quarter. About 6.04M shares traded or 50.09% up from the average. (NYSE:MRK) has risen 16.86% since February 1, 2017 and is uptrending.